Kurniawan J, Handayu AD, Aprilicia G, Bahri DR, Hasan I. Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Acta Med Indones [Internet]. 2025Jan.21 [cited 2025Dec.23];56(4):451. Available from: http://www.actamedindones.org/index.php/ijim/article/view/2625